Skip to main content

Cellebrite DI Ltd. (CLBT) Stock Forecast 2025 - AI Price Prediction & Analysis


Cellebrite DI Ltd. (CLBT) AI Stock Price Forecast & Investment Analysis

Cellebrite DI Ltd. Stock Price Chart and Technical Analysis

Loading Cellebrite DI Ltd. interactive price chart and technical analysis...

Cellebrite DI Ltd. (CLBT) - Comprehensive Stock Analysis & Investment Research

Deep dive into Cellebrite DI Ltd.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Cellebrite DI Ltd., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Cellebrite DI Ltd.: Cellebrite DI Ltd. operates in the Technology sector, establishing it as a mid-cap growth opportunity.

Cellebrite DI Ltd. (Stock Symbol: CLBT) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Cellebrite DI Ltd.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cellebrite DI Ltd.:

Market Capitalization: $4426 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Cellebrite DI Ltd. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Cellebrite DI Ltd.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Cellebrite DI Ltd. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Cellebrite DI Ltd.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Cellebrite DI Ltd.: Market positioning analysis based on available financial and operational metrics.

Cellebrite DI Ltd. strategically competes in the highly dynamic Services-Prepackaged Software marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

Cellebrite DI Ltd. (CLBT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Cellebrite DI Ltd. stock analysis.

Loading Cellebrite DI Ltd. comprehensive fundamental analysis and insider trading data...

Deep dive into Cellebrite DI Ltd.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Cellebrite DI Ltd. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Cellebrite DI Ltd.:

P/B Ratio 10.84x
Market Cap $4426M
Book Value/Share $1.67
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Cellebrite DI Ltd. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cellebrite DI Ltd.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Cellebrite DI Ltd.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Cellebrite DI Ltd.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Cellebrite DI Ltd.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Cellebrite DI Ltd.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Cellebrite DI Ltd. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Cellebrite DI Ltd.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Cellebrite DI Ltd.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Cellebrite DI Ltd.:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 244M

Latest Cellebrite DI Ltd. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Cellebrite DI Ltd. (CLBT) stock price and investment outlook.

, source: Insider Monkey

Greenhaven Road Capital, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, the Fund returned 8% net, ...

, source: Nasdaq

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago. These ...

, source: Insider Monkey

Greenhaven Road Capital, an investment management company, released its third-quarter 2022 investor letter. A copy of the same can be downloaded here. The fund declined in the third quarter, bringing ...

, source: Nasdaq

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.11 per share a year ago. These figures are ...

Cellebrite DI Ltd. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Cellebrite DI Ltd. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $4982M 19.9x 3.6x
ADBE Unlock Forecast - 30 Days FREE Trial $138277M 19.9x 11.8x
AEYE Unlock Forecast - 30 Days FREE Trial $162M -61.5x 22.0x
AI Unlock Forecast - 30 Days FREE Trial $2506M -16.8x 3.1x
ALKT Unlock Forecast - 30 Days FREE Trial $2313M -75.9x 6.7x
ALRM Unlock Forecast - 30 Days FREE Trial $2518M 19.6x 3.2x
ALSAF Unlock Forecast - 30 Days FREE Trial $45M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
APCX Unlock Forecast - 30 Days FREE Trial $5M -0.8x 2.1x
API Unlock Forecast - 30 Days FREE Trial $1444M x 2.2x
APPN Unlock Forecast - 30 Days FREE Trial $2054M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3254M -12.4x 14.5x
ATHR Unlock Forecast - 30 Days FREE Trial $72M x 12.2x
AVDX Unlock Forecast - 30 Days FREE Trial $2077M 1104.8x 3.0x
BAND Unlock Forecast - 30 Days FREE Trial $449M -30.3x 1.2x
BASE Unlock Forecast - 30 Days FREE Trial $1354M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2719M -11.9x 3.8x
BBAI Unlock Forecast - 30 Days FREE Trial $2658M -3.9x 10.0x
BL Unlock Forecast - 30 Days FREE Trial $3093M 35.2x 7.5x
BLIN Unlock Forecast - 30 Days FREE Trial $14M -2.4x 1.4x
BLKB Unlock Forecast - 30 Days FREE Trial $3051M 88.2x 34.7x
BMR Unlock Forecast - 30 Days FREE Trial $41M x 2.3x
BNZI Unlock Forecast - 30 Days FREE Trial $7M x 2.3x
BRZE Unlock Forecast - 30 Days FREE Trial $2766M -36.2x 4.6x
BSQKZ Unlock Forecast - 30 Days FREE Trial $48717M 16.5x 2.2x
BSY Unlock Forecast - 30 Days FREE Trial $16754M 65.9x 14.4x
CANG Unlock Forecast - 30 Days FREE Trial $965M x 0.2x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCLD Unlock Forecast - 30 Days FREE Trial $131M 11.6x 2.3x
CCLDO Unlock Forecast - 30 Days FREE Trial $899M 79.7x 16.0x
CCSI Unlock Forecast - 30 Days FREE Trial $482M 6.0x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $88606M 87.6x 17.7x
CERT Unlock Forecast - 30 Days FREE Trial $2033M 254.8x 1.9x
CFLT Unlock Forecast - 30 Days FREE Trial $7626M -15.7x 7.2x
CGNT Unlock Forecast - 30 Days FREE Trial $573M x 2.9x
CHKP Unlock Forecast - 30 Days FREE Trial $20412M x 7.3x
CLBT Unlock Forecast - 30 Days FREE Trial $4426M x 10.8x
CLPS Unlock Forecast - 30 Days FREE Trial $17M x 1.0x
COUR Unlock Forecast - 30 Days FREE Trial $1676M -14.2x 2.7x
CRM Unlock Forecast - 30 Days FREE Trial $234815M 35.2x 3.8x
CRNC Unlock Forecast - 30 Days FREE Trial $488M -0.5x 3.1x
CRWD Unlock Forecast - 30 Days FREE Trial $120163M 4606.3x 32.0x
CRWV Unlock Forecast - 30 Days FREE Trial $52246M x 19.7x
CVLT Unlock Forecast - 30 Days FREE Trial $7599M 93.7x 20.8x
CWAN Unlock Forecast - 30 Days FREE Trial $4611M 11.4x 2.3x
CXM Unlock Forecast - 30 Days FREE Trial $2014M 16.8x 3.7x
CYBR Unlock Forecast - 30 Days FREE Trial $24041M x 10.1x
DAY Unlock Forecast - 30 Days FREE Trial $10918M 222.8x 4.0x
DDD Unlock Forecast - 30 Days FREE Trial $570M -3.9x 2.4x
DDOG Unlock Forecast - 30 Days FREE Trial $54616M 438.4x 17.1x
DH Unlock Forecast - 30 Days FREE Trial $315M -1.3x 1.0x
DOCU Unlock Forecast - 30 Days FREE Trial $13498M 48.0x 6.8x
DRTTF Unlock Forecast - 30 Days FREE Trial $113M 29.2x 3.3x
DSGX Unlock Forecast - 30 Days FREE Trial $8274M x 5.5x
DT Unlock Forecast - 30 Days FREE Trial $14292M 29.0x 5.3x
DTSS Unlock Forecast - 30 Days FREE Trial $15M -6.8x 5.2x
DUOL Unlock Forecast - 30 Days FREE Trial $16121M 137.6x 16.5x
EA Unlock Forecast - 30 Days FREE Trial $50275M 48.3x 8.3x
EGAN Unlock Forecast - 30 Days FREE Trial $366M 11.4x 4.5x
EVCM Unlock Forecast - 30 Days FREE Trial $2004M -59.0x 2.7x
EXFY Unlock Forecast - 30 Days FREE Trial $150M -12.3x 1.1x
FALC Unlock Forecast - 30 Days FREE Trial $12M x x
FATN Unlock Forecast - 30 Days FREE Trial $60M x 3.0x
FCUL Unlock Forecast - 30 Days FREE Trial $8M x 174.7x
FNGR Unlock Forecast - 30 Days FREE Trial $90M -16.8x 6.0x
FROG Unlock Forecast - 30 Days FREE Trial $5437M -60.2x 6.6x
FRSH Unlock Forecast - 30 Days FREE Trial $3246M -49.0x 3.3x
FRSX Unlock Forecast - 30 Days FREE Trial $1622M x 273.6x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1135M -8.6x 1.2x
GEG Unlock Forecast - 30 Days FREE Trial $66M 5.1x 0.9x
GEGGL Unlock Forecast - 30 Days FREE Trial $1087M 84.3x 15.5x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $5676M x 6.4x
GMGI Unlock Forecast - 30 Days FREE Trial $133M -247.8x 1.1x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $7976M 654.1x 9.2x
GWRE Unlock Forecast - 30 Days FREE Trial $20609M 295.3x 14.1x
GXAI Unlock Forecast - 30 Days FREE Trial $12M -1.3x 0.8x
HPAI Unlock Forecast - 30 Days FREE Trial $119M x 7.3x
HUBS Unlock Forecast - 30 Days FREE Trial $22804M -5033.1x 11.0x
IDAI Unlock Forecast - 30 Days FREE Trial $8M -0.7x 3.3x
IFBD Unlock Forecast - 30 Days FREE Trial $9M x 0.1x
INFA Unlock Forecast - 30 Days FREE Trial $7522M 3931.5x 3.2x
INLX Unlock Forecast - 30 Days FREE Trial $50M 1318.3x 4.3x
INSE Unlock Forecast - 30 Days FREE Trial $209M 3.5x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3038M -173.7x 5.8x
INTU Unlock Forecast - 30 Days FREE Trial $180594M 46.7x 9.2x
JAMF Unlock Forecast - 30 Days FREE Trial $1305M -22.8x 1.7x
KC Unlock Forecast - 30 Days FREE Trial $46765M x 5.0x
KLTR Unlock Forecast - 30 Days FREE Trial $230M 17.7x 13.6x
KVYO Unlock Forecast - 30 Days FREE Trial $6645M -19.1x 6.1x
LAW Unlock Forecast - 30 Days FREE Trial $362M -12.7x 2.6x
LFLY Unlock Forecast - 30 Days FREE Trial $112M -0.3x -4.0x
LPSN Unlock Forecast - 30 Days FREE Trial $585M -0.5x -1.2x
MANH Unlock Forecast - 30 Days FREE Trial $11673M 52.8x 41.9x
MBLY Unlock Forecast - 30 Days FREE Trial $11392M -9.4x 0.9x
MGIC Unlock Forecast - 30 Days FREE Trial $917M x 4.4x
MLNK Unlock Forecast - 30 Days FREE Trial $1485M -46.1x 3.8x
MNDY Unlock Forecast - 30 Days FREE Trial $9122M x 7.7x
MQ Unlock Forecast - 30 Days FREE Trial $2233M 51.0x 2.7x
MSFT Unlock Forecast - 30 Days FREE Trial $3803309M 37.4x 11.1x
MTBLY Unlock Forecast - 30 Days FREE Trial $2421M x 50.1x
MTC Unlock Forecast - 30 Days FREE Trial $23M x x
MYPS Unlock Forecast - 30 Days FREE Trial $119M -24.1x 0.5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1429M 499.2x 1.8x
NCNO Unlock Forecast - 30 Days FREE Trial $2774M -119.0x 2.6x
NCSYF Unlock Forecast - 30 Days FREE Trial $8634M x 2.4x
NICE Unlock Forecast - 30 Days FREE Trial $8117M x 2.3x
NOW Unlock Forecast - 30 Days FREE Trial $185624M 111.8x 17.0x
ONTF Unlock Forecast - 30 Days FREE Trial $226M -6.7x 1.5x
OS Unlock Forecast - 30 Days FREE Trial $3897M x 10.1x
PATH Unlock Forecast - 30 Days FREE Trial $8637M 428.3x 5.2x
PAYC Unlock Forecast - 30 Days FREE Trial $11268M 27.1x 6.3x
PCOR Unlock Forecast - 30 Days FREE Trial $10606M -134.0x 8.7x
PCTY Unlock Forecast - 30 Days FREE Trial $8224M 36.2x 6.7x
PD Unlock Forecast - 30 Days FREE Trial $1463M -23.5x 8.1x
PLTR Unlock Forecast - 30 Days FREE Trial $422473M 553.5x 71.3x
PRCH Unlock Forecast - 30 Days FREE Trial $1759M 31.5x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1933M 39.8x 4.1x
PTC Unlock Forecast - 30 Days FREE Trial $24196M 47.2x 6.9x
QLYS Unlock Forecast - 30 Days FREE Trial $4609M 24.9x 9.1x
QTWO Unlock Forecast - 30 Days FREE Trial $3700M 757.6x 6.3x
RBLX Unlock Forecast - 30 Days FREE Trial $93223M -35.7x 263.9x
RBRK Unlock Forecast - 30 Days FREE Trial $14925M x 0.0x
RDVT Unlock Forecast - 30 Days FREE Trial $727M 83.5x 7.6x
RPD Unlock Forecast - 30 Days FREE Trial $1167M 45.7x 12.9x
RTCJF Unlock Forecast - 30 Days FREE Trial $28M x 1.1x
S Unlock Forecast - 30 Days FREE Trial $5542M -25.6x 3.7x
SAIL Unlock Forecast - 30 Days FREE Trial $12245M -73.2x 1.8x
SBET Unlock Forecast - 30 Days FREE Trial $925M x 2.0x
SEMR Unlock Forecast - 30 Days FREE Trial $1059M 169.4x 3.8x
SHOP Unlock Forecast - 30 Days FREE Trial $206423M x 17.0x
SMSI Unlock Forecast - 30 Days FREE Trial $14M -0.2x 0.6x
SNAL Unlock Forecast - 30 Days FREE Trial $1M -7.0x 0.1x
SNPS Unlock Forecast - 30 Days FREE Trial $83019M 41.6x 3.0x
SPNS Unlock Forecast - 30 Days FREE Trial $2405M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $4065M 49.0x 4.3x
SSNC Unlock Forecast - 30 Days FREE Trial $19408M 24.1x 2.8x
SSTI Unlock Forecast - 30 Days FREE Trial $141M -38.0x 1.9x
SVCO Unlock Forecast - 30 Days FREE Trial $165M x 2.1x
TAOP Unlock Forecast - 30 Days FREE Trial $14M x 0.9x
TDC Unlock Forecast - 30 Days FREE Trial $2048M 18.6x 11.6x
TEAM Unlock Forecast - 30 Days FREE Trial $39302M -233.9x 29.2x
TENB Unlock Forecast - 30 Days FREE Trial $3518M -81.5x 10.0x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $8439M x 5.7x
TTWO Unlock Forecast - 30 Days FREE Trial $47802M -9.7x 13.7x
TWLO Unlock Forecast - 30 Days FREE Trial $17074M 843.4x 2.1x
TYL Unlock Forecast - 30 Days FREE Trial $23907M 77.9x 6.6x
U Unlock Forecast - 30 Days FREE Trial $14598M -13.5x 4.6x
VBIX Unlock Forecast - 30 Days FREE Trial $31M x 6.8x
VEEV Unlock Forecast - 30 Days FREE Trial $46497M 57.4x 7.0x
VPRB Unlock Forecast - 30 Days FREE Trial $2M x x
VRNS Unlock Forecast - 30 Days FREE Trial $6755M -27.4x 19.8x
VWAV Unlock Forecast - 30 Days FREE Trial $32M x x
WBSR Unlock Forecast - 30 Days FREE Trial $16M x x
WEAV Unlock Forecast - 30 Days FREE Trial $497M -36.7x 6.3x
WFCF Unlock Forecast - 30 Days FREE Trial $67M 32.5x 6.7x
WHEN Unlock Forecast - 30 Days FREE Trial $83M x 61.0x
WIMI Unlock Forecast - 30 Days FREE Trial $90M x 0.1x
XPER Unlock Forecast - 30 Days FREE Trial $306M -4.3x 0.7x
XYZ Unlock Forecast - 30 Days FREE Trial $46744M 15.8x 2.1x
ZDGE Unlock Forecast - 30 Days FREE Trial $43M -4.8x 1.5x
ZETA Unlock Forecast - 30 Days FREE Trial $3918M -26.5x 5.8x
ZSPC Unlock Forecast - 30 Days FREE Trial $26M x -3.2x

Frequently Asked Questions - Cellebrite DI Ltd. Stock Forecast

How accurate are Cellebrite DI Ltd. stock predictions?

Our AI model demonstrates 35% historical accuracy for CLBT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Cellebrite DI Ltd. stock price forecasts?

Our analysis considers Cellebrite DI Ltd.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Cellebrite DI Ltd. a good investment in 2025?

Based on our AI analysis, Cellebrite DI Ltd. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Cellebrite DI Ltd. forecasts updated?

Cellebrite DI Ltd. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Cellebrite DI Ltd. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Cellebrite DI Ltd. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...